APA

Andrieux J., Roche-Lestienne C., Geffroy S., Desterke C., Grardel N., Plantier I., Selleslag D., Demory J., Laï J., Leleu X., Le Bousse-Kerdiles C. & Vandenberghe P. (20071109). Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. : Cancer genetics and cytogenetics.

Chicago

Andrieux Joris, Roche-Lestienne Catherine, Geffroy Sandrine, Desterke Christophe, Grardel Nathalie, Plantier Isabelle, Selleslag Dominik, Demory Jean-Loup, Laï Jean-Luc, Leleu Xavier, Le Bousse-Kerdiles Caroline and Vandenberghe Peter. 20071109. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. : Cancer genetics and cytogenetics.

Harvard

Andrieux J., Roche-Lestienne C., Geffroy S., Desterke C., Grardel N., Plantier I., Selleslag D., Demory J., Laï J., Leleu X., Le Bousse-Kerdiles C. and Vandenberghe P. (20071109). Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. : Cancer genetics and cytogenetics.

MLA

Andrieux Joris, Roche-Lestienne Catherine, Geffroy Sandrine, Desterke Christophe, Grardel Nathalie, Plantier Isabelle, Selleslag Dominik, Demory Jean-Loup, Laï Jean-Luc, Leleu Xavier, Le Bousse-Kerdiles Caroline and Vandenberghe Peter. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. : Cancer genetics and cytogenetics. 20071109.